Inhibition of nitric oxide synthesis during induced cholestasis ameliorates hepatocellular injury by facilitating S-nitrosothiol homeostasis

Laboratory Investigation

Volumn 90, Issue 1, 2010, Pages 116-127

  López Sánchez, Laura M ^a   Corrales, Fernando J ^b   Barcos, Montserrat ^a   Espejo, Isabel ^a   Mũoz Castãeda, Juan R ^a   Rodríguez Ariza, Antonio ^a  

^a HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

^b UNIVERSITY OF NAVARRA   (Spain)

Author keywords

Adh5; Cholestasis; GSNOR; NO; S nitrosoglutahione; S nitrosylation

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BETAINE HOMOCYSTEINE METHYLTRANSFERASE; BILIRUBIN; GAMMA GLUTAMYLTRANSFERASE; GLUTATHIONE REDUCTASE; HEAT SHOCK PROTEIN 90; LACTATE DEHYDROGENASE; LIVER ENZYME; MESSENGER RNA; METHIONINE SYNTHASE; MULTIDRUG RESISTANCE PROTEIN 2; NITRIC OXIDE; PROTEIN DISULFIDE ISOMERASE; S NITROSOTHIOL; TAUROURSODEOXYCHOLIC ACID; THIOUREA DERIVATIVE;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILE DUCT DISEASE; BILE DUCT LIGATION; BILIRUBIN BLOOD LEVEL; CHOLESTASIS; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; FIBROSIS; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; HOMEOSTASIS; LACTATE DEHYDROGENASE BLOOD LEVEL; LIVER CELL DAMAGE; LIVER CIRCULATION; MALE; NITROSYLATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS INHIBITION; RAT; SHAM PROCEDURE; WISTAR RAT;

ALDEHYDE OXIDOREDUCTASES; ANIMALS; ATP-BINDING CASSETTE TRANSPORTERS; BILE DUCTS; CHOLAGOGUES AND CHOLERETICS; CHOLESTASIS; DOWN-REGULATION; ENZYME INHIBITORS; HOMEOSTASIS; ISOTHIURONIUM; LIGATION; LIVER; MALE; NITRIC OXIDE; NITROSATION; PROTEINS; RATS; RATS, WISTAR; RNA, MESSENGER; S-NITROSOTHIOLS; TAUROCHENODEOXYCHOLIC ACID;

EID: 73349108789     PISSN: 00236837     EISSN: 15300307     Source Type: Journal    
DOI: 10.1038/labinvest.2009.104     Document Type: Article

References (50)

1. Guicciardi ME, Gores GJ. Cholestatic hepatocellular injury: what do we know and how should we proceed. J Hepatol 2005;42:297-300.
2. Krahenbuhl S, Talos C, Lauterburg BH, et al. Reduced antioxidative capacity in liver mitochondria from bile duct ligated rats. Hepatology 1995;22:607-612.
3. Padillo FJ, Cruz A, Navarrete C, et al. Melatonin prevents oxidative stress and hepatocyte cell death induced by experimental cholestasis. Free Radic Res 2004;38:697-704.
4. Reinehr R, Graf D, Haussinger D. Bile salt-induced hepatocyte apoptosis involves epidermal growth factor receptor-dependent CD95 tyrosine phosphorylation. Gastroenterology 2003;125:839-853.
5. Sokol RJ, Winklhoferroob BM, Devereaux MW, et al. Generation of hydroperoxides in isolated rat hepatocytes and hepatic mitochondria exposed to hydrophobic bile-acids. Gastroenterology 1995;109:1249-1256.
6. Sokol RJ, Mckim JM, Goff MC, et al. Vitamin E reduces oxidant injury to mitochondria and the hepatotoxicity of taurochenodeoxycholic acid in the rat. Gastroenterology 1998;114:164-174.
7. Assimakopoulos SF, Scopa CD, Charonis A, et al. Experimental obstructive jaundice disrupts intestinal mucosal barrier by altering occludin expression: beneficial effect of bombesin and neurotensin. J Am Coll Surg 2004;198:748-757.
8. Arriero MM, Lopez-Farre A, Fryeiro O, et al. Expression of inducible nitric oxide synthase in the liver of bile duct-ligated Wistar rats with modulation by lymphomononuclear cells. Surgery 2001;129:255-266.
9. Hokari A, Zeniya M, Esumi H, et al. Detection of serum nitrite and nitrate in primary biliary cirrhosis: possible role of nitric oxide in bile duct injury. J Gastroenterol Hepatol 2002;17:308-315.
10. Grattagliano I, Portincasa P, Palmieri VO, et al. Mutual changes of thioredoxin and nitrosothiols during biliary cirrhosis: results from humans and cholestatic rats. Hepatology 2007;45:331-339.
11. Stamler JS, Lamas S, Fang FC. Nitrosylation. the prototypic redox-based signaling mechanism. Cell 2001;106:675-683.
12. Mannick JB, Schonhoff CM. Nitrosylation: the next phosphorylation? Arch Biochem Biophys 2002;408:1-6.
13. Martinez-Ruiz A, Lamas S. S-nitrosylation: a potential new paradigm in signal transduction. Cardiovasc Res 2004;62:43-52.
14. Foster MW, McMahon TJ, Stamler JS. S-nitrosylation in health and disease. Trends Mol Med 2003;9:160-168.
15. Lopez-Sanchez LM, Collado JA, Corrales FJ, et al. S-Nitrosation of proteins during D-galactosamine-induced cell death in human hepatocytes. Free Radic Res 2007;41:50-61.
16. Lopez-Sanchez LM, Corrales FJ, Gonzalez R, et al. Alteration of S-nitrosothiol homeostasis and targets for protein S-nitrosation in human hepatocytes. Proteomics 2008;8:4709-4720.
17. Ebrahimkhani MR, Kiani S, Oakley F, et al. Naltrexone, an opioid receptor antagonist, attenuates liver fibrosis in bile duct ligated rats. Gut 2006;55:1606-1616.
18. Szabo C, Southan GJ, Thiemermann C. Beneficial effects and improved survival in rodent models of septic shock with S-methylisothiourea sulfate, a potent and selective inhibitor of inducible nitric oxide synthase. Proc Natl Acad Sci USA 1994;91:12472-12476.
19. Bazzani C, Bertolini A, Guarini S. Inhibition of nitric oxide synthases enhances the effect of ACTH in hemorrhagic shock. Life Sci 1997;61:1889-1897.
20. Fickert P, Zollner G, Fuchsbichler A, et al. Effects of ursodeoxycholic and cholic acid feeding on hepatocellular transporter expression in mouse liver. Gastroenterology 2001;121:170-183.
21. Beuers U, Bilzer M, Chittattu A, et al. Tauroursodeoxycholic acid inserts the apical conjugate export pump, Mrp2, into canalicular membranes and stimulates organic anion secretion by protein kinase C-dependent mechanisms in cholestatic rat liver. Hepatology 2001;33:1206-1216.
22. Lopez-Sanchez LM, Corrales FJ, De la MM, et al. Detection and proteomic identification of S-nitrosated proteins in human hepatocytes. Methods Enzymol 2008;440:273-281.
23. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 2001;25:402-408.
24. Bogert PT, LaRusso NF. Cholangiocyte biology. Curr Opin Gastroenterol 2007;23:299-305.
25. Werneburg NW, Yoon JH, Higuchi H, et al. Bile acids activate EGF receptor via a TGF-alpha-dependent mechanism in human cholangiocyte cell lines. Am J Physiol Gastrointest Liver Physiol 2003;285:G31-G36.
26. Roskams T, Desmet V. Ductular reaction and its diagnostic significance. Semin Diagn Pathol 1998;15:259-269.
27. Diaz R, Kim JW, Hui JJ, et al. Evidence for the epithelial to mesenchymal transition in biliary atresia fibrosis. Hum Pathol 2008;39:102-115.
28. Omenetti A, Porrello A, Jung Y, et al. Hedgehog signaling regulates epithelial-mesenchymal transition during biliary fibrosis in rodents and humans. J Clin Invest 2008;118:3331-3342.
29. Patsenker E, Popov Y, Stickel F, et al. Inhibition of integrin alphavbeta6 on cholangiocytes blocks transforming growth factor-beta activation and retards biliary fibrosis progression. Gastroenterology 2008;135:660-670.
30. Ishimura N, Bronk SF, Gores GJ. Inducible nitric oxide synthase upregulates cyclooxygenase-2 in mouse cholangiocytes promoting cell growth. Am J Physiol Gastrointest Liver Physiol 2004;287: G88-G95.
31. Ishimura N, Bronk SF, Gores GJ. Inducible nitric oxide synthase up-regulates Notch-1 in mouse cholangiocytes: implications for carcinogenesis. Gastroenterology 2005;128:1354-1368.
32. Vera M, Nieto N. Hepatic stellate cells and alcoholic liver disease. Rev Esp Enferm Dig 2006;98:674-684. (Pubitemid 350259141)
33. Nanji AA, Jokelainen K, Lau GK, et al. Arginine reverses ethanol-induced inflammatory and fibrotic changes in liver despite continued ethanol administration. J Pharmacol Exp Ther 2001;299:832-839. (Pubitemid 33104949)
34. Trauner M, Arrese M, Soroka CJ, et al. The rat canalicular conjugate export pump (Mrp2) is down-regulated in intrahepatic and obstructive cholestasis. Gastroenterology 1997;113:255-264.
35. Elferink MG, Olinga P, Draaisma AL, et al. LPS-induced downregula-tion of MRP2 and BSEP in human liver is due to a posttranscrip-tional process. Am J Physiol Gastrointest Liver Physiol 2004;287: G1008-G1016.
36. Vos TA, Hooiveld GJ, Koning H, et al. Up-regulation of the multidrug resistance genes, Mrp1 and Mdr1b, and down-regulation of the organic anion transporter, Mrp2, and the bile salt transporter, Spgp, in endotoxemic rat liver. Hepatology 1998;28:1637-1644.
37. Southan GJ, Szabo C, Thiemermann C. Isothioureas: potent inhibitors of nitric oxide synthases with variable isoform selectivity. Br J Pharmacol 1995;114:510-516.
38. Olinga P, Merema MT, de Jager MH, et al. Rat liver slices as a tool to study LPS-induced inflammatory response in the liver. J Hepatol 2001;35:187-194. (Pubitemid 32803473)
39. Yang YY, Huang YT, Lee KC, et al. Chronic administration of ursodeoxycholic acid decreases portal pressure in rats with biliary cirrhosis. Clin Sci (Lond) 2009;116:71-79.
40. Liu L, Hausladen A, Zeng M, et al. A metabolic enzyme for S-nitrosothiol conserved from bacteria to humans. Nature 2001;410: 490-494.
41. Liu L, Yan Y, Zeng M, et al. Essential roles of S-nitrosothiols in vascular homeostasis and endotoxic shock. Cell 2004;116:617-628.
42. Garvey EP, Oplinger JA, Tanoury GJ, et al. Potent and selective inhibition of human nitric oxide synthases. Inhibition by non-amino acid isothioureas. J Biol Chem 1994;269:26669-26676.
43. Krahenbuhl L, Schafer M, Krahenbuhl S. Reversibility of hepatic mitochondrial damage in rats with long-term cholestasis. J Hepatol 1998;28:1000-1007.
44. Lang C, Berardi S, Schafer M, et al. Impaired ketogenesis is a major mechanism for disturbed hepatic fatty acid metabolism in rats with long-term cholestasis and after relief of biliary obstruction. J Hepatol 2002;37:564-571.
45. Collinsova M, Strakova J, Jiracek J, et al. Inhibition of betaine-homocysteine S-methyltransferase causes hyperhomocysteinemia in mice. J Nutr 2006;136:1493-1497.
46. Zou CG, Gao SY, Zhao YS, et al. Homocysteine enhances cell proliferation in hepatic myofibroblastic stellate cells. J Mol Med 2009;87:75-84.
47. Biagini MR, Tozzi A, Marcucci R, et al. Hyperhomocysteinemia and hypercoagulability in primary biliary cirrhosis. World J Gastroenterol 2006;12:1607-1612.
48. Ebrahimkhani MR, Sadeghipour H, Dehghani M, et al. Homocysteine alterations in experimental cholestasis and its subsequent cirrhosis. Life Sci 2005;76:2497-2512.
49. Mato JM, Lu SC. Role of S-adenosyl-L-methionine in liver health and injury. Hepatology 2007;45:1306-1312.
50. Avila MA, Corrales FJ, Ruiz F, et al. Specific interaction of methionine adenosyltransferase with free radicals. Biofactors 1998;8:27-32.